Phase I evaluation of low-dose suramin as chemosensitizer of doxorubicin in dogs with naturally occurring cancers.

MLA

Kosarek, Carrie E., et al. “Phase I Evaluation of Low-Dose Suramin as Chemosensitizer of Doxorubicin in Dogs with Naturally Occurring Cancers.” Journal of Veterinary Internal Medicine, vol. 20, no. 5, Sept. 2006, pp. 1172–77. EBSCOhost, https://doi.org/10.1892/0891-6640(2006)20[1172:pieols]2.0.co;2.

APA

Kosarek, C. E., Hu, X., Couto, C. G., Kisseberth, W. C., Green, E. M., Au, J. L. S., & Wientjes, M. G. (2006). Phase I evaluation of low-dose suramin as chemosensitizer of doxorubicin in dogs with naturally occurring cancers. Journal of Veterinary Internal Medicine, 20(5), 1172–1177. https://doi.org/10.1892/0891-6640(2006)20[1172:pieols]2.0.co;2

Chicago

Kosarek, Carrie E, Xiao Hu, C Guillermo Couto, William C Kisseberth, Eric M Green, Jessie L S Au, and M Guillaume Wientjes. 2006. “Phase I Evaluation of Low-Dose Suramin as Chemosensitizer of Doxorubicin in Dogs with Naturally Occurring Cancers.” Journal of Veterinary Internal Medicine 20 (5): 1172–77. doi:10.1892/0891-6640(2006)20[1172:pieols]2.0.co;2.